Second line of treatment for HER2-positive gastric cancer: an evolving issue

od Roviello, Giandomenico, Catalano, Martina, D’Angelo, Alberto, Palmieri, Valeria Emma
Wydane w Rep Pract Oncol Radiother (2021)

Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights

od Roviello, Giandomenico, D'Angelo, Alberto, Roudi, Raheleh, Petrioli, Roberto, Mini, Enrico
Wydane w J Oncol (2019)

Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis

od Roviello, Giandomenico, Corona, Silvia Paola, D’Angelo, Alberto, Rosellini, Pietro, Nobili, Stefania, Mini, Enrico
Wydane w Int J Mol Sci (2020)

MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy

od Rodriquenz, Maria Grazia, Roviello, Giandomenico, D’Angelo, Alberto, Lavacchi, Daniele, Roviello, Franco, Polom, Karol
Wydane w J Clin Med (2020)

Mutant p53 as an Antigen in Cancer Immunotherapy

od Sobhani, Navid, D’Angelo, Alberto, Wang, Xu, Young, Ken H., Generali, Daniele, Li, Yong
Wydane w Int J Mol Sci (2020)

Advances in anti-BRAF therapies for lung cancer

od Roviello, Giandomenico, D’Angelo, Alberto, Sirico, Marianna, Pittacolo, Matteo, Conter, Felipe Umpierre, Sobhani, Navid
Wydane w Invest New Drugs (2021)

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

od Roviello, Giandomenico, D'Angelo, Alberto, Petrioli, Roberto, Roviello, Franco, Cianchi, Fabio, Nobili, Stefania, Mini, Enrico, Lavacchi, Daniele
Wydane w Transl Oncol (2020)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

od Sobhani, Navid, Ianza, Anna, D’Angelo, Alberto, Roviello, Giandomenico, Giudici, Fabiola, Bortul, Marina, Zanconati, Fabrizio, Bottin, Cristina, Generali, Daniele
Wydane w Cells (2018)

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption

od Sobhani, Navid, Neeli, Praveen Kumar, D’Angelo, Alberto, Pittacolo, Matteo, Sirico, Marianna, Galli, Ilaria Camilla, Roviello, Giandomenico, Nesi, Gabriella
Wydane w Int J Mol Sci (2021)

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer

od Sobhani, Navid, D’Angelo, Alberto, Pittacolo, Matteo, Roviello, Giandomenico, Miccoli, Anna, Corona, Silvia Paola, Bernocchi, Ottavia, Generali, Daniele, Otto, Tobias
Wydane w Cells (2019)

Methylene Blue—Current Knowledge, Fluorescent Properties, and Its Future Use

od Cwalinski, Tomasz, Polom, Wojciech, Marano, Luigi, Roviello, Giandomenico, D’Angelo, Alberto, Cwalina, Natalia, Matuszewski, Marcin, Roviello, Franco, Jaskiewicz, Janusz, Polom, Karol
Wydane w J Clin Med (2020)

Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

od D’Angelo, Alberto, Sobhani, Navid, Chapman, Robert, Bagby, Stefan, Bortoletti, Carlotta, Traversini, Mirko, Ferrari, Katia, Voltolini, Luca, Darlow, Jacob, Roviello, Giandomenico
Wydane w Cancers (Basel) (2020)

Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma

od D’Angelo, Alberto, Sobhani, Navid, Roviello, Giandomenico, Bagby, Stefan, Bonazza, Deborah, Bottin, Cristina, Giudici, Fabiola, Zanconati, Fabrizio, De Manzini, Nicolo, Guglielmi, Alessandra, Generali, Daniele
Wydane w PLoS One (2019)

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer

od Roviello, Giandomenico, Ramello, Monica, Catalano, Martina, D’Angelo, Alberto, Conca, Raffaele, Gasperoni, Silvia, Dreoni, Lorenzo, Petrioli, Roberto, Ianza, Anna, Nobili, Stefania, Aieta, Michele, Mini, Enrico
Wydane w Sci Rep (2020)